Home
About us
Overview
Patents
History
Publications
Create A Better World
Products & Services
Umbilical Cord Lining Stem Cells
Cord Banking
GlobalCord
CALECIM®
SOLLAGEN™
Contract Research
R&D
Burns
Wounds & Resurfacing
Age-related Macular Degeneration
Bones & Cartilage
Corneal Resurfacing
Diabetes
Haemophilia A
Heart Disease
Hearing & Balance Disorders
Lupus
Neurological
Parkinsons
Cosmeceuticals
Related Stem Cell Research
Future Research
Our Team
Management Team
Senior Advisors
Clinical Trial Partners
Scientific Advisory Board and KOL
Our Partners
Distributors
Cord Banks
Affiliates
Animal Care
Newsroom
In The News
Announcements and Press Releases
Support
Contact us
FAQ
Terms & conditions

CellResearch Corp

Home
About us
Overview
Patents
History
Publications
Create A Better World
Products & Services
Umbilical Cord Lining Stem Cells
Cord Banking
GlobalCord
CALECIM®
SOLLAGEN™
Contract Research
R&D
Burns
Wounds & Resurfacing
Age-related Macular Degeneration
Bones & Cartilage
Corneal Resurfacing
Diabetes
Haemophilia A
Heart Disease
Hearing & Balance Disorders
Lupus
Neurological
Parkinsons
Cosmeceuticals
Related Stem Cell Research
Future Research
Our Team
Management Team
Senior Advisors
Clinical Trial Partners
Scientific Advisory Board and KOL
Our Partners
Distributors
Cord Banks
Affiliates
Animal Care
Newsroom
In The News
Announcements and Press Releases
Support
Contact us
FAQ
Terms & conditions

 

Announcements and Press Releases

 
 

Global leader in the fight against diabetes Professor Andrew Boulton joins Singapore biotech CellResearch Corporation’s (CRC) Scientific Advisory Board.

Oct 2022

 

CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world’s premier diabetic foot conference (DFCon) in Los Angeles

Sep 2022

 

CellResearch Corporation (CRC) announces positive results of Phase I study for CorLiCyte®

Sep 2022

 

Singapore biotech company CellResearch Corporation has appointed former Organogenesis Executive and Lead Inventor of Apligraft® Paul Kemp (PhD) to its Scientific Advisory Board

Aug 2022

 

CellResearch Corporation (CRC) announces new Scientific Advisory Board (SAB) member: Dr David Armstrong

Jul 2022

 

CALECIM® Cosmeceuticals appoints former Zalora and Skin Inc executive Cooper McGuire as Chief Operating Officer

May 2022

 

CellResearch Corporation (CRC) has named former Mundipharma and Eirgen executive Olivia Sutton as its new Head of Projects

 

Mar 2022

 
 
 

CellResearch Corporation (CRC) has been awarded SME Designation by the European Medicines Agency (EMA)

Feb 2022

 

Cutting edge umbilical cord lining stem cell therapy developed by Singaporean biotech granted Innovation Passport by UK regulators

October 2021

 
 
 

 CellResearch Corporation - Source of cGMP Umbilical Cord Lining Stem Cells for COVID-19 Related Investigator Initiated Clinical Trials
May 2020

 

 CellResearch to Further R&D in Stem Cell Therapies and Regenerative Medicine
Apr 2020

 

 CALECIM® partners Menarini Asia-Pacific to expand reach of its stem cell skin care products in the region
May 2019

 

CellResearch Corporation Pte. Ltd. Develops Process to Produce World’s Purest Population of Mesenchymal Stem Cells
September 2018

 

CALECIM® Cosmeceuticals Proud to Announce Mitchel P. Goldman MD as Chairman of the CALECIM® Professional Medical Advisory Board
June 2017

 

CellResearch Corporation Extends Umbilical Cord Tissue Banking Services Across the US through Partnership with University of Colorado, Anschutz Medical Campus and CariCord
November 2016

 

CellResearch Corporation launches scientifically formulated skincare line enhanced with the benefits of original stem-cell technology
September 2015

 

CellResearch Corporation receives new US patent approval for exclusive stem cell technology amidst new partnerships
June 2015

 

Services and Research Collaboration Agreement between CellResearch Corporation Pte Ltd and the University of Colorado School of Medicine
June 2015

 

US Patent Grant
June 2015

 

New Applications For Cord Lining Stem Cells: Diabetes and Wound Healing
April 2006

 

Singapore Biotech Firm Discovers New Source of Stem Cells
July 2005

 

Potential Stem Cells From Umbilical Cord
August 2004

 
Back to Top
In The News

CellResearch Corporation Pte Ltd
137 Market Street, Unit 08-02 Grace Global Raffles Building Singapore 048943  P:+65 6444 9968 E:info@cellresearchcorp.com